Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||
| Cash income from operating activities | -444.60%-12.19M | 98.00%3.54M | 1.79M | 0.00%50K | 50K | |||
| Other cash income from operating activities | -444.60%-12.19M | 98.00%3.54M | --1.79M | ---- | 0.00%50K | --50K | ---- | ---- |
| Cash paid | -4.39%-5.59M | -61.12%-5.35M | -143.67%-3.32M | -63.03%-1.36M | -3.79%-836.31K | -111.34%-805.79K | -381.27K | |
| Payments to suppliers for goods and services | ---- | -4.39%-5.59M | -61.12%-5.35M | -143.67%-3.32M | -63.03%-1.36M | -3.79%-836.31K | -111.34%-805.79K | ---381.27K |
| Direct interest paid | -974.07%-580K | ---54K | ---- | ---- | ---- | ---- | ---- | ---- |
| Direct interest received | ---- | -73.16%49K | 893.79%182.58K | 27.48%18.37K | -54.48%14.41K | -13.84%31.66K | 483.07%36.75K | --6.3K |
| Operating cash flow | -520.56%-12.77M | 39.22%-2.06M | -2.44%-3.38M | -154.34%-3.3M | -72.14%-1.3M | 1.87%-754.65K | -105.10%-769.04K | ---374.97K |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | -379.01%-108.11M | 19.91%-22.57M | -1.38%-28.18M | -100.22%-27.8M | -183.92%-13.88M | -80.07%-4.89M | -55.96%-2.72M | -1.74M |
| Capital expenditure reported | 49.07%-7.78M | 32.00%-15.29M | 8.55%-22.48M | -107.83%-24.58M | -142.57%-11.83M | -72.49%-4.88M | -67.17%-2.83M | ---1.69M |
| Net PPE purchase and sale | -2,528.28%-47.49M | -122.35%-1.81M | 74.61%-812.67K | -59.07%-3.2M | -4,660.22%-2.01M | ---42.28K | ---- | ---50.41K |
| Net intangibles purchas and sale | ---- | ---- | ---- | --1.19K | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | ---52.84M | ---- | ---- | 55.48%-20K | ---44.92K | ---- | ---- | ---- |
| Net other investing changes | ---- | -11.95%-5.48M | ---4.89M | ---- | ---- | -75.00%27.73K | --110.9K | ---- |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | -379.01%-108.11M | 19.91%-22.57M | -1.38%-28.18M | -100.22%-27.8M | -183.92%-13.88M | -80.07%-4.89M | -55.96%-2.72M | ---1.74M |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | 315.38%141.01M | 88.06%33.95M | -45.65%18.05M | 17.07%33.22M | 388.86%28.37M | 150.80%5.8M | -61.40%2.31M | 5.99M |
| Net issuance payments of debt | ---9.73M | ---- | --124.81K | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | 351.94%154.23M | 89.76%34.13M | -46.28%17.98M | 17.96%33.48M | 388.96%28.38M | 150.80%5.8M | -61.40%2.31M | --5.99M |
| Net other financing activities | -875.98%-3.49M | -211.05%-358K | 63.86%-115.09K | -2,794.88%-318.44K | ---11K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | 315.38%141.01M | 88.06%33.95M | -45.65%18.05M | 17.07%33.22M | 388.86%28.37M | 150.80%5.8M | -61.40%2.31M | --5.99M |
| Net cash flow | ||||||||
| Beginning cash position | 200.15%13.98M | -74.37%4.66M | 13.23%18.17M | 459.56%16.05M | 5.89%2.87M | -30.17%2.71M | --3.88M | ---- |
| Current changes in cash | 116.01%20.13M | 168.97%9.32M | -739.17%-13.52M | -83.97%2.11M | 8,165.08%13.19M | 113.64%159.61K | -130.17%-1.17M | --3.88M |
| Effect of exchange rate changes | ---- | ---- | ---- | 177.77%8.46K | ---10.87K | ---- | ---- | ---- |
| End cash Position | 144.04%34.11M | 200.15%13.98M | -74.37%4.66M | 13.23%18.17M | 459.56%16.05M | 5.89%2.87M | -30.17%2.71M | --3.88M |
| Free cash from | -251.08%-68.04M | 27.99%-19.38M | 13.41%-26.92M | -105.34%-31.08M | -166.87%-15.14M | -57.76%-5.67M | -69.91%-3.6M | ---2.12M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |